Skip to content
Screener

Perspective Therapeutics CATX Total Current Assets

Total Current Assets at other companies

Eli Lilly logo
Eli LillyLLY
$64.67B+29.7%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$373.16M+127%
Immunome logo
ImmunomeIMNM
$538.45M+94.1%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$1.03B-14.5%
uniQure logo
uniQureQURE
$834.27M+104%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$392.33M+74.4%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$29.3M-21.7%
Net income-$26.8M-24.7%
EPS (diluted)-$0.22+24.1%

Balance sheet

See full
Cash & equivalents$48.5M+68.1%
Total debt$3.9M+11.1%
Total equity$323.9M+21.9%
Total assets$392.0M+26.2%

Cash flow

See full
Operating cash flow-$20.7M-3.5%
CapEx$14.2M+1,284%
Free cash flow-$34.8M-66.1%

Valuation

See full
Market cap$342.14M+25.3%
Enterprise value$297.56M+20.1%

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp

Returns & leverage

See full
Return on equity-39.5%+14.0pp
Debt / equity0.0×
Current ratio6.6×-8.5×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Perspective Therapeutics’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:34 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-342512
Line itemJune 30, 2026December 31, 2025
Short-term investments188,388114,108
Accounts receivable, net of allowance for doubtful accounts: $375 for each period2696
Prepaid expenses and other current assets4,3783,646
Total current assets241,523148,389
Noncurrent assets:
Property and equipment, net107,79776,597
Right-of-use asset2,1961,500
Intangible assets, in-process research and development40,00040,000

ITEM 1 - FINANCIAL STATEMENTS

FAQ

What is Perspective Therapeutics's total current assets?
Perspective Therapeutics (CATX) reported total current assets of $241.52M in Q2 2026.
How has Perspective Therapeutics's total current assets changed year-over-year?
Perspective Therapeutics's total current assets increased by 23.3% year-over-year, from $195.96M to $241.52M.
What is the long-term trend for Perspective Therapeutics's total current assets?
Over 5 years (2020 to 2025), Perspective Therapeutics's total current assets has grown at a 64.6% compound annual growth rate (CAGR), from $12.29M to $148.39M.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Perspective Therapeutics's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude